Vor Biopharma, Inc. (VOR)
Vor Biopharma has a market cap or net worth of $286.38 million. The enterprise value is $75.61 million.
Vor Biopharma has 37.29 million shares outstanding. The number of shares has increased by 16,089.03% in one year.
|Shares Change (YoY)||+16,089.03%|
|Shares Change (QoQ)||+0.25%|
|Owned by Insiders (%)||10.79%|
|Owned by Institutions (%)||81.67%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 25.20, with a Debt / Equity ratio of 0.08.
|Debt / Equity||0.08|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -40.30%, which is considered low. The company has a ROIC of -86.20%.
|Return on Equity (ROE)||-40.30%|
|Return on Assets (ROA)||-30.90%|
|Return on Capital (ROIC)||-86.20%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$571,377|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-57.33%|
|50-Day Moving Average||11.23|
|200-Day Moving Average||13.87|
|Average Volume (30 Days)||95,827|
Short Selling Information
|Short % of Shares Out||4.81%|
|Short % of Float||11.16%|
|Short Ratio (days to cover)||13.57|
|Net Income Common||-69.71M|
|Earnings Per Share (EPS)||-$2.89|
The company has $228.38 million in cash and $17.61 million in debt, giving a net cash position of $210.77 million or $5.65 per share.
|Cash & Cash Equivalents||228.38M|
|Net Cash Per Share||$5.65|
|Book Value Per Share||6.25|
In the last 12 months, operating cash flow was -$65.19 million and capital expenditures -$4.20 million, giving a free cash flow of -$69.39 million.
|Operating Cash Flow||-65.19M|
|Free Cash Flow||-69.39M|
|FCF Per Share||n/a|
Dividends & Yields
Vor Biopharma does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|